WHO ICTRP trial
A pharmacogenomic study on cisplatin-induced nausea and vomiting.(TRIPLE…
JPRN-UMIN000009335 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000009335 |
|---|---|
| Public title | A pharmacogenomic study on cisplatin-induced nausea and vomiting.(TRIPLE Pharmacogenomics Study) |
| Scientific title | A pharmacogenomic study on cisplatin-induced nausea and vomiting.(TRIPLE Pharmacogenomics Study) - TRIPLE Pharmacogenomics Study |
| Primary sponsor | Department of Clinical Pharmacology and Genitics, School of Pharmaceutical Science, Univercity of Shizuoka |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Malignant tumor (lung cancer,gastric cancer,esophagus cancer,cervical cancer,endometrial cancer,head and neck cancer,etc) |
| Registration date | Nov 19, 2012 |
| Target size | 200 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: